In:
Blood, American Society of Hematology, Vol. 123, No. 24 ( 2014-06-12), p. 3832-3842
Kurzfassung:
We report that ruxolitinib reduces murine GVHD via increased Treg numbers. We demonstrate the potent activity of ruxolitinib treatment in patients with corticosteroid-refractory GVHD.
Materialart:
Online-Ressource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2013-12-543736
Sprache:
Englisch
Verlag:
American Society of Hematology
Publikationsdatum:
2014
ZDB Id:
1468538-3
ZDB Id:
80069-7
Permalink